查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632612

全球生物可吸收冠状动脉支架市场：市场规模、份额及趋势分析（按材料、药物、最终用途、地区及细分市场，2025-2030 年）

Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Material (Polymer, Metal), By Drug (Sirolimus, Novalimus), By End Use (Outpatient, Inpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

生物可吸收冠状动脉支架市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球生物可吸收冠状动脉支架市场规模预计到 2030 年将达到 2.101 亿美元，2025 年至 2030 年期间的复合年增长率为 4.1%。

生物可吸收支架主要针对年轻人，可溶解装置完全吸收后，他们的动脉将恢復正常功能。文明病和相关风险因素的流行促进了动脉粥状硬化相关心臟事件的增加。文明病和相关风险因素的流行是动脉粥状硬化相关心臟事件增加的原因。这导致了全球疾病的流行和年轻人中选择性经皮冠状动脉介入治疗（PCI）的高发生率。

第二代生物可吸收心臟冠状动脉支架有哪些特性？吸取过去的教训，製造商开发出了新一代生物可吸收支架，其支柱更细、吸收时间更短、径向力更强。 Amaranth 已开发出三种这样的支架，重点在于支柱厚度。每个支柱都较细。最新震级为100微米。

推动该市场发展的另一个因素是选择性手术数量众多，因为与冠状动脉绕道手术手术相比，PCI 的侵入性较小。在世界上大多数地区，由于缺乏不当程序的审核，导致冠状动脉支架置入术数量增加。因此，由于选择性 PCI 手术数量众多，尤其是在亚太地区和欧洲，市场预计会成长。

生物可吸收冠状动脉支架市场报告重点

  • 预计聚合物领域将在 2024 年占据最大的市场占有率，达到 50.2%，而金属领域预计在预测期内以最快的复合年增长率增长。
  • Sirolimus细分市场将在 2024 年占据最大份额，达到 63.1%，而诺瓦利司细分市场预计将在 2025 年至 2030 年期间以最快的复合年增长率增长。
  • 门诊设施部门在 2024 年占据最大的市场占有率，为 61.9%，预计在预测期内将以最快的复合年增长率成长。
  • 开发生物可吸收冠状动脉支架是各公司为占据更高的市场占有率而采取的策略努力的核心。以临床为目标的公司正在开发具有改进设计规格的第二代生物可吸收产品，包括具有更薄支柱的设备，以实现更快的吸收率，从而与黄金标准药物释放型金属支架相媲美。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 生物可吸收冠状动脉支架市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 生物可吸收冠状动脉支架市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 管道分析

第 4 章 生物可吸收冠状动脉支架市场：材料估计与趋势分析

  • 全球生物可吸收冠状动脉支架市场：按材料分類的仪表板
  • 全球生物可吸收冠状动脉支架市场：依材料差异分析
  • 全球生物可吸收冠状动脉支架市场（按材料划分） (以收益为准)
  • 聚合物
  • 金属

第 5 章生物可吸收冠状动脉支架市场：药物特定估计和趋势分析

  • 全球生物可吸收冠状动脉支架市场：代理商仪表板
  • 全球生物可吸收冠状动脉支架市场：药物趋势分析
  • 全球生物可吸收冠状动脉支架市场（按药物分类）（以收益为准）
  • Sirolimus
  • 诺维莫司
  • 其他的

6. 生物可吸收冠状动脉支架市场：依最终用途的估计与趋势分析

  • 全球生物可吸收冠状动脉支架市场：依最终用途划分
  • 全球生物可吸收冠状动脉支架市场：依最终用途进行差异分析
  • 全球生物可吸收冠状动脉支架市场按最终用途划分（以收益为准）
  • 住院设施
  • 门诊设施

7. 生物可吸收冠状动脉支架市场：区域估计和趋势分析（按国家、材料、药物和最终用途）

  • 区域控制面板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 最新趋势和影响分析：按主要製造商
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业市场占有率分析（2024年）
  • 公司简介
    • Biotronik
    • Meril Life Sciences Pvt. Ltd.
    • Elixir Medical
    • REVA Medical, LLC
    • Arterial Remodeling Technologies SA
    • LifeTech Scientific
    • Microport Scientific Corporation
    • LEPU Medical
Product Code: GVR-2-68038-234-1

Bioresorbable Coronary Stents Market Growth & Trends:

The global bioresorbable coronary stents market size is expected to reach USD 210.1 million by 2030, expanding at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Bioresorbable Coronary Stents Market Report Highlights:

  • The polymer segment held the largest market share of 50.2% in 2024 and the metal segment is anticipated to grow at the fastest CAGR over the forecast period.
  • The sirolimus segment held the largest market share of 63.1% in 2024 and the Novalimus segment is anticipated to grow at the fastest CAGR from 2025 to 2030.
  • The outpatient facilities segment held the largest market share of 61.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
  • Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Material
    • 1.2.2. Drug
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Material outlook
    • 2.2.2. Drug outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Bioresorbable Coronary Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Development in biocompatible materials
      • 3.2.1.2. Rising incidence of cardiovascular diseases
      • 3.2.1.3. Advancements in minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High initial cost
      • 3.2.2.2. Material recalls
  • 3.3. Bioresorbable Coronary Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Bioresorbable Coronary Stents Market: Material Estimates & Trend Analysis

  • 4.1. Global Bioresorbable Coronary Stents Market: Material Dashboard
  • 4.2. Global Bioresorbable Coronary Stents Market: Material Movement Analysis
  • 4.3. Global Bioresorbable Coronary Stents Market by Material, Revenue
  • 4.4. Polymer
    • 4.4.1. Polymer market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Metal
    • 4.5.1. Metal market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Bioresorbable Coronary Stents Market: Drug Estimates & Trend Analysis

  • 5.1. Global Bioresorbable Coronary Stents Market: Drug Dashboard
  • 5.2. Global Bioresorbable Coronary Stents Market: Drug Movement Analysis
  • 5.3. Global Bioresorbable Coronary Stents Market by Drug, Revenue
  • 5.4. Sirolimus
    • 5.4.1. Sirolimus market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Novalimus
    • 5.5.1. Novalimus market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Bioresorbable Coronary Stents Market: End Use Estimates & Trend Analysis

  • 6.1. Global Bioresorbable Coronary Stents Market: End Use Dashboard
  • 6.2. Global Bioresorbable Coronary Stents Market: End Use Movement Analysis
  • 6.3. Global Bioresorbable Coronary Stents Market by End Use, Revenue
  • 6.4. Inpatient Facilities
    • 6.4.1. Inpatient facilities market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Outpatient Facilities
    • 6.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis by Country, Material, Drug and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Biotronik
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Material benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Meril Life Sciences Pvt. Ltd.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Material benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Elixir Medical
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Material benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. REVA Medical, LLC
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Material benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Arterial Remodeling Technologies SA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Material benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. LifeTech Scientific
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Material benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Microport Scientific Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Material benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. LEPU Medical
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Material benchmarking
      • 8.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 3 Global bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 4 Global bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global bioresorbable coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 8 North America bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 9 North America bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 11 U.S. bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 12 U.S. bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 14 Canada bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 15 Canada bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 17 Mexico bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 18 Mexico bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 21 Europe bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 22 Europe bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 24 Germany bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 25 Germany bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 27 UK bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 28 UK bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 30 France bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 31 France bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 33 Italy bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 34 Italy bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 36 Spain bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 37 Spain bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 39 Denmark bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 40 Denmark bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 42 Sweden bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 43 Sweden bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 45 Norway bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 46 Norway bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 52 China bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 53 China bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 55 Japan bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 56 Japan bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 58 India bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 59 India bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 61 South Korea bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 62 South Korea bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 64 Australia bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 65 Australia bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 67 Thailand bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 68 Thailand bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America bioresorbable coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 71 Latin America bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 72 Latin America bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 74 Brazil bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 75 Brazil bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 77 Argentina bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 78 Argentina bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 83 South Africa bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 84 South Africa bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 89 UAE bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 90 UAE bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait bioresorbable coronary stents market, by material, 2018 - 2030 (USD Million)
  • Table 92 Kuwait bioresorbable coronary stents market, by drug, 2018 - 2030 (USD Million)
  • Table 93 Kuwait bioresorbable coronary stents market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Dental chair market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Bioresorbable Coronary Stents Market: Material Outlook Key Takeaways
  • Fig. 15 Global Bioresorbable Coronary Stents Market: Material Movement Analysis
  • Fig. 16 Global Polymer Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Metal Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Bioresorbable Coronary Stents Market: Drug Outlook Key Takeaways
  • Fig. 19 Global Bioresorbable Coronary Stents Market: Drug Movement Analysis
  • Fig. 20 Global Sirolimus Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Novalimus Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Bioresorbable Coronary Stents Market: End Use Outlook Key Takeaways
  • Fig. 24 Global Bioresorbable Coronary Stents Market: End Use Movement Analysis
  • Fig. 25 Global Inpatient Facilities Market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Outpatient Facilities Market, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional outlook, 2024 & 2030
  • Fig. 29 Global Bioresorbable Coronary Stents Market: Region Movement Analysis
  • Fig. 30 North America Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 36 UK Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia pacific Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 45 China Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 46 India Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Bioresorbable Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 58 Strategy framework